References
- Nafasi L, Rahmani R, Shafiee A, et al. High reloading dose of atorvastatin prior to percutaneous coronary intervention can reduce periprocedural myocardial infarction. Curr Med Res Opin 2013 Aug 19 [Epub ahead of print]. doi: 10.1185/03007995.2013.834249
- Athyros VG, Tziomalos K, Florentin M, et al. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect? Curr Med Res Opin 2010;26:839-42
- Hao PP, Chen YG, Wang JL, et al. Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease. Clin Exp Pharmacol Physiol 2010;37:496-500
- Paraskevas KI, Veith FJ, Liapis CD, et al. Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update. Curr Vasc Pharmacol 2013;11:112-20
- Paraskevas KI, Giannoukas AD, Mikhailidis DP. Statins and infrainguinal vascular bypass procedures. Curr Vasc Pharmacol 2013;11:51-7
- Li Y, Liu Y, Fu L, et al. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012;7:e34450
- Byrne J, Spence MS, Fretz E, et al. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). Am J Cardiol 2009;103:507-11
- Goyal SN, Bharti S, Krishnamurthy B, et al. Impact of metabolic syndrome on re-stenosis development: role of drug-eluting stents. Diab Vasc Dis Res 2012;9:177-88